BIOMAT Database Logo BIOMAT Database Logo

Coronary artery perfusion during percutaneous transluminal coronary angioplasty. 1986

H V Anderson, and D L Nelson, and P P Leimgruber, and G S Roubin, and A R Gruentzig

UI MeSH Term Description Entries
D007552 Isotonic Solutions Solutions having the same osmotic pressure as blood serum, or another solution with which they are compared. (From Grant & Hackh's Chemical Dictionary, 5th ed & Dorland, 28th ed) Solutions, Isotonic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D001802 Blood Substitutes Substances that are used in place of blood, for example, as an alternative to BLOOD TRANSFUSIONS after blood loss to restore BLOOD VOLUME and oxygen-carrying capacity to the blood circulation, or to perfuse isolated organs. Artificial Blood,Artificial Erythrocytes,Artificial Hemoglobin,Blood, Artificial,Erythrocyte Substitutes,Hemoglobin Substitutes,Red Cell Substitutes,Artificial Bloods,Artificial Erythrocyte,Artificial Hemoglobins,Blood Substitute,Bloods, Artificial,Cell Substitute, Red,Cell Substitutes, Red,Erythrocyte Substitute,Erythrocyte, Artificial,Erythrocytes, Artificial,Hemoglobin Substitute,Hemoglobin, Artificial,Hemoglobins, Artificial,Red Cell Substitute,Substitute, Blood,Substitute, Erythrocyte,Substitute, Hemoglobin,Substitute, Red Cell,Substitutes, Blood,Substitutes, Erythrocyte,Substitutes, Hemoglobin,Substitutes, Red Cell
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D003331 Coronary Vessels The veins and arteries of the HEART. Coronary Arteries,Sinus Node Artery,Coronary Veins,Arteries, Coronary,Arteries, Sinus Node,Artery, Coronary,Artery, Sinus Node,Coronary Artery,Coronary Vein,Coronary Vessel,Sinus Node Arteries,Vein, Coronary,Veins, Coronary,Vessel, Coronary,Vessels, Coronary
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug

Related Publications

H V Anderson, and D L Nelson, and P P Leimgruber, and G S Roubin, and A R Gruentzig
Perfusion stenting for coronary dissection during percutaneous transluminal coronary angioplasty.
January 1994, Indian heart journal,
H V Anderson, and D L Nelson, and P P Leimgruber, and G S Roubin, and A R Gruentzig
Abrupt coronary artery occlusion during percutaneous transluminal coronary angioplasty.
June 1992, American heart journal,
H V Anderson, and D L Nelson, and P P Leimgruber, and G S Roubin, and A R Gruentzig
Left main coronary artery dissection during percutaneous transluminal coronary angioplasty.
January 1986, Catheterization and cardiovascular diagnosis,
H V Anderson, and D L Nelson, and P P Leimgruber, and G S Roubin, and A R Gruentzig
ECG changes during selective percutaneous transluminal coronary artery angioplasty.
June 1986, Lancet (London, England),
H V Anderson, and D L Nelson, and P P Leimgruber, and G S Roubin, and A R Gruentzig
Coronary artery bypass following percutaneous transluminal coronary angioplasty.
August 1985, The Annals of thoracic surgery,
H V Anderson, and D L Nelson, and P P Leimgruber, and G S Roubin, and A R Gruentzig
Percutaneous transluminal coronary angioplasty of coronary artery embolism.
March 1992, Catheterization and cardiovascular diagnosis,
H V Anderson, and D L Nelson, and P P Leimgruber, and G S Roubin, and A R Gruentzig
Coronary artery vasomotion after percutaneous transluminal coronary angioplasty.
November 1997, Clinical cardiology,
H V Anderson, and D L Nelson, and P P Leimgruber, and G S Roubin, and A R Gruentzig
Coronary artery spasm following percutaneous transluminal coronary angioplasty.
January 1987, Cleveland Clinic journal of medicine,
H V Anderson, and D L Nelson, and P P Leimgruber, and G S Roubin, and A R Gruentzig
Percutaneous transluminal coronary angioplasty versus coronary artery bypass.
September 1985, The New England journal of medicine,
H V Anderson, and D L Nelson, and P P Leimgruber, and G S Roubin, and A R Gruentzig
[Percutaneous transluminal coronary angioplasty after coronary artery bypass].
January 1989, Harefuah,
Copied contents to your clipboard!